Clinical trial
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
NCT00156377 · University Hospital Muenster, Other · Completed
Key facts
| NCT number | NCT00156377 |
|---|---|
| Title | Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections |
| Official title | Investigation of the Influence of Intranasal Mupirocin on the Prevalence of S. Aureus Nosocomial Infections by Eradication of Intranasal S. Aureus |
| Lead sponsor | University Hospital Muenster, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cross Infection, Staphylococcal Infections |
| Intervention type | Drug |
| Interventions | Mupirocin |
| Enrollment | 1,200 |
| Start date | Nov 1, 2002 |
| First posted | Sep 12, 2005 |
| Last update posted | May 25, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: